Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Enliven Therapeutics (ELVN) Q3 2021 Earnings
ELVN
9
Nov
Expected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
-2.96
-2.16
-1.36
-0.56
Details
Expected EPS
-0.8457
Actual EPS
-2.2
Surprise EPS
-1.35
Surprise Percent
+160.14%
Description
Enliven Therapeutics (ELVN) has reported earnings of -2.2 per share for Q3 2021.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login